Not currently recruiting at UCSF
Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection
Summary
- Eligibility
- for people ages 18-65 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Vir Biotechnology, Inc.
- ID
- NCT04856085
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 260 study participants
- Last Updated